Signals™ Medical Review Solution

With the staggering complexity and volume of clinical trial data, the risk of missing a safety signal for medical monitors and safety review teams is growing exponentially. In a recent informal survey, 37% of respondents cited the risk of missing a safety signal as their single greatest challenge in medical review, followed by slow decision making and the high cost of supporting analytics infrastructure. This risk can place organizations in danger of a delayed or rejected submission or even a market withdrawal, while compromising the safety of trial subjects.